期刊文献+

维持性腹膜透析治疗患者左心室功能及相关因素分析 被引量:6

Analysis of left ventricular dysfunction and correlative factors in patients on maintenance peritoneal dialysis
下载PDF
导出
摘要 目的对维持性腹膜透析治疗患者左心室功能情况及相关因素进行分析。方法选取我院肾脏病血液净化科2006~2010年期间收治的维持性腹膜透析治疗患者131例,按性别分为男性腹膜透析组和女性腹膜透析组;对所有患者均常规检测血清肌酐、尿素氮、白蛋白、血红蛋白、血钙、血磷、血清总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、血全段甲状旁腺激素(i-PTH),超敏C反应蛋白(hs-CRP);高压液相色谱法方法检测血浆同型半胱氨酸;利用超声心动图检查评价左心室功能;利用公式计算肾小球滤过率及体质量指数(BMI)。结果两组患者年龄、舒张压、血肌酐、尿毒氮、尿酸、TC水平及BMI差异有统计学意义,男性腹膜透析组患者舒张压、血肌酐、尿毒氮、尿酸水平及BMI高于女性腹膜透析组(P<0.05或<0.01);其余指标差异无统计学意义;两组患者左心室收缩功能异常发生率差异无统计学意义,男性腹膜透析组左心室舒张末内径52(47,53)mm大于女性腹膜透析组49(45,53)mm,差异具有统计学意义(P<0.01);多因素Logistic回归分析显示,年龄、血浆白蛋白、血清TC、低密度脂蛋白胆固醇平是腹膜透析治疗患者左心室收缩功能障碍的危险因素;而收缩压是腹膜透析治疗患者左心室舒张功能障碍的危险因素。结论腹膜透析治疗患者左心室肥厚发生率较高,纠正低蛋白血症,增加透析剂量,控制血压,降低血脂可能有助于改善腹膜透析患者左心室功能异常。 Objective To analyze left ventricular dysfunction and related factors in patients on maintenance peritoneal dialysis. Methods A total of 131 patients who received chronic peritoneal dialysis were included in this study. Patients were divided into two groups: male peritoneal dialysis group and female peritoneal dialysis group. Blood examinations such as blood urine nitrogen, creatinine, uric acid, hemoglobin, calcium, phosphate, triglyceride, total cholesterol, LDL-C, HDL-C, parathyroid hormone (PTH) and high sensitivity C-reactive protein were measured, and echocardiography was performed in all patients. The level of homocysteine was measured by high pressure liquid chromatography. Glomerular filtration rate and body mass index(BMI) were also calculated. Results There were significant difference in age, BMi,level of blood urine nitrogen, creatinine, uric acid,total cholesterol and diastolic blood pressure between two groups ( P ~0.05 or ~0.01). There were left ventricular contract dysfunction and diastolic dysfunction in both patient groups, and male group had higher rate of diastolic dysfunction with significant difference, LVDd male to female, 52 (47.53) mm larger than female 49 (45.53) mm (P d0.05). The level of albumin, total cholesterol,LDL-C and age were risk factors for left ventricular contract dysfunction. Meanwhile, systolic blood pressure was risk a factor for diastolic dysfunction chronic peritoneal dialysis patients. Conclusion The ratio of left ventricular hypertrophy is higher in maintenance peritoneal dialysis patients. Increase of albumin level, close of dialysis, control of blood pressure, improvement of lipidemia may be helpful to improve left ventricular function of patients on maintenance peritoneal dialysis.
出处 《临床荟萃》 CAS 2012年第23期2028-2031,共4页 Clinical Focus
关键词 腹膜透析 肥大 左心室 低蛋白血症 peritoneal dialysis hypertrophy, left ventricular hypoproteinemia
  • 相关文献

参考文献13

  • 1Glassock RJ, Pecoits-Filho R, Barberato SH. Left ventricuIar mass in chronic kidney disease and ESRD[J]. Clin J Am Soc Nephrol, 2009,4 (Suppl 1 ) : S79-91.
  • 2Stiihlinger MC, Stanger O. Asymmetric dimethyl-L-arginine (ADMA) :a possible link between homocyst(e)ine and endothelial dysfunction[J].Curt Drug Metab, 2005,6 ( 1 ) : 3-14.
  • 3Kessler M, Zannad F, Lehert P, et al. Predictors of cardiovascular events in patients with end-stage renal disease: an analysis from the Fosinopril in dialysis study[J]. Nephrol Dial Transplant, 2007,22 (12) : 35?3-35?9.
  • 4Foley RN, Curtis BM, Randell EW, et al. Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease[J]. Clin J Am Soc Nephrol, 2010,5 (5) : 805-813.
  • 5Tonbul Z, Altintepe L, Sozlti C et al. The association of peritoneal transport properties with 24-hour blood pressure levels in CAPD patients. [J]. Petit Dial Int, 2003,23(1) :46-52.
  • 6Wang AY, Wang M, Woo J, et al. Inflammation, residual kidney function,and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients[J]. J Am Soc Nephrol,2004,15(8) 2186-2194.
  • 7Heinz J,Kropf S,Luley C, et al. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis[J]. Am J Kidney Dis, 2009,54 (3) : 478-489.
  • 8Ferechide D, Radulescu D. Hyperhomocysteinemia in renal diseases[J]. J Med Life, 2009,2 (1) : 53-59.
  • 9Konings CJ, Kooman JP, Sehonck M, et al. Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis [J]. Perit Dial Int, 2002,22 (4) : 477-487.
  • 10Asci G,Ozkahya M,Duman S, et al. Volume control associate with better cardiac function in long-term peritoneal dialysis patients[J]. Petit Dial Int, 2006,26 (1) :85-88.

同被引文献73

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部